The
common stock equivalents associated with the following securities are excluded from the calculation of weighted average dilutive common
shares because their inclusion would have been anti-dilutive:
Schedule of Weighted Average Dilutive Common Shares Anti-dilutive
| | |
March 31, | |
| | |
2025 | | |
2024 | |
| | |
| | |
| |
| Options | |
| 11,457,004 | | |
| 6,932,004 | |
| Warrants | |
| 22,287,545 | | |
| 15,693,445 | |
| Convertible notes [1] | |
| 14,655,067 | | |
| 13,656,427 | |
| Convertible preferred stock | |
| 21,464,713 | | |
| 20,030,110 | |
| Total | |
| 69,864,329 | | |
| 56,311,986 | |
| [1] |
Convertible
notes are assumed to be converted at the rate of $0.75 per common share, which is the conversion price as of March 31, 2025 and 2024.
However, such conversion rates are subject to adjustment under certain circumstances, such as stock splits and stock dividends, which
may result in the issuance of common shares greater than the amount indicated. |
|